Short-term effectiveness and safety of third-line antiretroviral regimens among patients in Western India
Pujari, S.N.; Makane, A.; Lodha, A.; Bele, V.; Joshi, K.
Journal of Acquired Immune Deficiency Syndromes 65(2): E82-E84
2014
ISSN/ISBN: 1944-7884 PMID: 24442229 DOI: 10.1097/qai.0b013e3182a6104aDocument Number: 579967
Document emailed within 0-6 h
Related Documents
Humphreys, E.H.; Chang, L.W.; Harris, J. 2010: Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy Cochrane Database of Systematic Reviews 6: Cd006517Pujari, S.; Dravid, A.; Gupte, N.; Joshi, K.; Bele, V. 2008: Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India Medscape Journal of Medicine 10(8): 196
Bender, M.A.; Kumarasamy, N.; Mayer, K.H.; Wang, B.; Walensky, R.P.; Flanigan, T.; Schackman, B.R.; Scott, C.A.; Lu, Z.; Freedberg, K.A. 2010: Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 50(3): 416-425
Duvivier, C.; Ghosn, J.; Assoumou, L.; Soulié, C.; Peytavin, G.; Calvez, V.; Génin, M.èl.A.é; Molina, J.-M.; Bouchaud, O.; Katlama, C.; Costagliola, D.; Beucler, I.; Dion, E.; Raffi, F.; Delfraissy, J.F.; Commoy, M.J.; Massip, P.; Garraffo, R.; Mazetier, L.; Izopet, J.; Chêne, G.; Racheline, A.; Jarousse, B.; Abgrall, S.; Obenga, G.; Phung, B.; Gerbe, J.; Bentata, M.; Honoré, P.; Rami, A.; Delcey, V.; Drener, M.; Parrinello, M.; Miailhes, P.; Lebouche, B.; Kouadjo, K.; Benmakhlouf, N.; Goujard, C.; Miquel, A.; Quetainmont, Y.; Rannou, M.T.; Perronne, C.; de Truchis, P.; Berthé, H.; Jeantils, V.; Tassi, S.; Rozenbaum, W.; Slama, L.; Chakvetaze, C.; Galanaud, P.; Boué, F.; Delavalle, A.M.; Lefebvre, B.; Bollens, D.; Meynard, J.L.; Oua 2008: Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial Journal of Antimicrobial ChemoTherapy 62(4): 797-808
Gaita, F.; Haissaguerre, M.; Di Donna, P.; Scaglione, M.; Riccardi, R.; Bocchiardo, M.; Richiardi, E.; Warin, J.F. 1993: Nodal reentry tachycardia: short- and long-term effectiveness and safety of a selective ablation technique of the slow pathway Giornale Italiano di Cardiologia 23(6): 563-574
Khan, S.; Das, M.; Andries, A.; Deshpande, A.; Mansoor, H.; Saranchuk, P.; Isaakidis, P. 2014: Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India Global Health Action 7: 24861
D'Almeida, C.; Essi, M.-J.é; Camara, M.; Coriat, B. 2011: Access to second-line antiretroviral therapeutic regimens in low-resource settings: experiences from Cameroon Journal of Acquired Immune Deficiency Syndromes 57(Suppl 1): S55-S58
Villalba, N.; Soriano, V.; Gómez-Cano, M.; Castilla, J.; Mas, A.; González-Lahoz, J. 1997: Short-term efficacy and safety of stavudine in pretreated HIV-infected patients Antiviral Therapy 2(3): 185-189
Neogi, U.; Heylen, E.; Shet, A.; Chandy, S.; Shamsunder, R.; Sönnerborg, A.; Ekstrand, M.L. 2013: Long-term efficacy of first line antiretroviral therapy in Indian HIV-1 infected patients: a longitudinal cohort study Plos one 8(1): E55421
Newberne, J.W. 1973: Assessment of safety data from patients on short and long-term perhexiline therapy Postgraduate Medical Journal 49(Suppl 3): 125-132
Negredo, E.; Paredes, R.; Peraire, J.; Pedrol, E.; Côté, H.; Gel, S.; Fumoz, C.R.; Ruiz, L.; Abril, V.; Rodriguez de Castro, E.; Ochoa, C.; Martinez-Picado, J.; Montaner, J.; Rey-Joly, C.; Clotet, B. 2004: Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study Antiviral Therapy 9(6): 889-893
Binagwaho, A.; Pegurri, E.; Drobac, P.C.; Mugwaneza, P.; Stulac, S.N.; Wagner, C.M.; Karema, C.; Tsague, L. 2013: Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda Plos one 8(2): E54180
Gol'dshtein, V.D.; Komissarenko, I.B.; Churilova, R.I.; Kulik, E.I.; Niamtsu, E.A. 1984: Effectiveness of short-term chemotherapy in patients with newly detected destructive pulmonary tuberculosis Problemy Tuberkuleza 1: 29-34
Allam, R.Reddy.; Murhekar, M.V.; Bhatnagar, T.; Uthappa, C.K.; Chava, N.; Rewari, B.B.; Venkatesh, S.; Mehendale, S. 2014: Survival probability and predictors of mortality and retention in care among patients enrolled for first-line antiretroviral therapy, Andhra Pradesh, India, 2008-2011 Transactions of the Royal Society of Tropical Medicine and Hygiene 108(4): 198-205
Phillips, A.N.; Pillay, D.; Garnett, G.; Bennett, D.; Vitoria, M.; Cambiano, V.; Lundgren, J. 2011: Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings Aids 25(6): 843-850
Castelli, G.; Squassante, L.; Uleri, S.; Zanferrari, G. 1991: Different dosage regimens of ranitidine in the short-term therapy of duodenal ulcer: a multicentre trial International Journal of Clinical Pharmacology Research 11(1): 41-49
Stringer, J.S.A.; Mwango, A.J.; Giganti, M.J.; Mulenga, L.; Levy, J.W.; Stringer, E.M.; Mulenga, P.; Saag, M.S.; Musonda, P.; Williams, F.B.; Reid, S.E.; Chi, B.H. 2012: Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study International Journal of Epidemiology 41(2): 448-459
Duan, C.; Li, T.; Han, Z. 2001: Short-term and long-term effectiveness of endovascular embolization in treating intracranial aneurysms Zhonghua Yi Xue Za Zhi 81(10): 579-582
Omair, M.A.; Phumethum, V.; Johnson, S.R. 2012: Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis Clinical and Experimental Rheumatology 30(2 Suppl 71: S55-S59
Zhou, J.; Jaquet, A.; Bissagnene, E.; Musick, B.; Wools-Kaloustian, K.; Maxwell, N.; Boulle, A.; Wehbe, F.; Masys, D.; Iriondo-Perez, J.; Hemingway-Foday, J.; Law, M.; Bissagene, E.; Boulle, A.; Braitstein, P.; Colebunders, R.; Dabis, F.; Diero, L.; Dyer, D.; Goco, N.; Graber, C.; Huebner, R.; Jaquet, A.; Krolewiecki, A.; Kumarasamy, N.; Lau, B.; Masys, D.; McFadden, D.; McKaig, R.; Mehta, U.; Mofenson, L.; Orrell, C.; Roe, J.; Schechter, M.; Schwarze, L.; Williams, C.; Wollf Reyes, M.J.; Wools-Kaloustian, K.; Zhang, F.J.; Zhou, J.; Allou, G.; Bacon, M.; Boulle, A.; Braitstein, P.; Colebunders, R.; Duda, S.; Dyer, D.; Egger, M.; Ekouevi, D.K.; Goco, N.; Graber, C.; Hartwell, T.; H 2012: Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America Journal of the International Aids Society 15(1): 5